BioSpace News Archive

Drug Development

RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021

Two new analyses evaluate pharmacological and clinical advantages of Talicia® as first-line H. pylori therapy over clarithromycin-based regimens

October 25, 2021
·
18 min read
Business

Alcyone Therapeutics Strengthens Executive Team with New Senior Leadership Appointments

Alcyone Therapeutics today announced four key appointments to its executive leadership team, bringing significant expertise in neuroscience and genetic medicines development.

October 25, 2021
·
4 min read
Lone Star Bio

OncoNano Announces $18.4 Million Equity Investment by the Cancer Prevention and Research Institute of Texas

OncoNano Medicine, Inc. today announced that the Cancer Prevention and Research Institute of Texas (CPRIT) will convert $18.4 million in grant award funding into an equity investment in OncoNano.

October 25, 2021
·
4 min read
Drug Development

Concert Pharmaceuticals Completes Enrollment in THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has completed patient enrollment in THRIVE-AA1, the first Phase 3 clinical trial to evaluate the efficacy and safety of CTP‑543, an oral Janus kinase (JAK) inhibitor, in adult patients with moderate to severe alopecia areata.

October 25, 2021
·
5 min read
Business

Bristol Myers Squibb Announces Earnings Call Time Change; Third Quarter 2021 Earnings Call to Occur on October 27, 2021 at 10 a.m. (Eastern Time)

Bristol Myers Squibb (NYSE:BMY) today announced that it has changed the timing of its previously announced earnings conference call. The Company will now host a conference call to discuss results for the third quarter of 2021 on Wednesday, October 27, 2021 at 10:00 a.m. ET .

October 25, 2021
·
1 min read
Genetown

Mevion Selected to Equip Compact Proton Therapy Center in Kansas City

The physician-led center will have the first Mevion compact proton therapy system in Kansas

October 25, 2021
·
3 min read
Pharm Country

Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a New Istaroxime PatentAnticipated New Patent Will Provide Intellectual Property Protection Until Late 2039

Windtree Therapeutics, Inc. today announced the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance of new patent claims for istaroxime administration.

October 25, 2021
·
6 min read
Medtronic Canada announces commercial launch of MazorX, the first dedicated robotic spinal surgery platform in Canada

Medtronic Canada ULC, a subsidiary of Medtronic plc today announced the commercial launch of the Mazor™ X System (herein referred to as Mazor) for robotic-guided spine surgery.

October 25, 2021
·
3 min read
Biotech Bay

Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients

Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients could experience significant improvements in survival if treated with accelerated partial breast irradiation (APBI) delivered using the Accuray CyberKnife

October 25, 2021
·
7 min read
Business

BridgeBio Pharma, Inc. Appoints Pioneering National Leader in Genomics and Workforce Diversity Hannah Valantine to its Board of Directors

BridgeBio Pharma, Inc. today announced that it has added a new independent director to its board: Hannah Valantine , M.D.

October 25, 2021
·
3 min read